Compartir
Tumors of the Central Nervous System, Volume 9: Lymphoma, Supratentorial Tumors, Glioneuronal Tumors, Gangliogliomas, Neuroblastoma in Adults, Astrocy (en Inglés)
Hayat, M. A. (Autor)
·
Springer
· Tapa Dura
Tumors of the Central Nervous System, Volume 9: Lymphoma, Supratentorial Tumors, Glioneuronal Tumors, Gangliogliomas, Neuroblastoma in Adults, Astrocy (en Inglés) - Hayat, M. A.
219,43 €
230,98 €
Ahorras: 11,55 €
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 31 de Julio y el
Lunes 19 de Agosto.
Lo recibirás en cualquier lugar de España entre 1 y 5 días hábiles luego del envío.
Reseña del libro "Tumors of the Central Nervous System, Volume 9: Lymphoma, Supratentorial Tumors, Glioneuronal Tumors, Gangliogliomas, Neuroblastoma in Adults, Astrocy (en Inglés)"
The ninth volume in this essential series discusses key advances in our understanding of neoplasms in the human central nervous system. This publication deals with various aspects of nine separate types of brain tumors. With 70 contributors from 17 nations, this edition offers an unrivalled thoroughness and breadth of coverage that includes the very latest research results on the following tumor types: astrocytoma, lymphoma, supratentorial and glioneuronal tumors, gangliogliomas, neuroblastoma in adults, hemangioma, and ependymoma. The content introduces new technologies and their applications in diagnosis, treatment and therapy of tumors. It explains molecular profiling techniques that enable oncologists to select appropriate therapies for clinical trials, and discusses a number of surgical treatments, including resection and radiosurgery. Volume 9 is interspersed with color illustrations and tables depicting many of the results. This volume joins its fellow publications in a valuable series that fully explores controversies and debates in CNS cancer therapy, and furthers the scientific quest for effective therapies to combat cancer in all its forms.
